170 related articles for article (PubMed ID: 12468829)
21. A combination of etanercept and methotrexate for the treatment of refractory juvenile idiopathic arthritis: a pilot study.
Schmeling H; Mathony K; John V; Keysser G; Burdach S; Horneff G
Ann Rheum Dis; 2001 Apr; 60(4):410-2. PubMed ID: 11247875
[TBL] [Abstract][Full Text] [Related]
22. Henoch Schönlein purpura following etanercept treatment of rheumatoid arthritis.
Duffy TN; Genta M; Moll S; Martin PY; Gabay C
Clin Exp Rheumatol; 2006; 24(2 Suppl 41):S106. PubMed ID: 16859610
[No Abstract] [Full Text] [Related]
23. Etanercept improves active polyarticular juvenile rheumatoid arthritis.
Martini A
Clin Exp Rheumatol; 2001; 19(2):122-4. PubMed ID: 11326472
[No Abstract] [Full Text] [Related]
24. Demyelinating disease and cutaneous lymphocitic vasculitis after etanercept therapy in a patient with rheumatoid arthritis.
Clemente RE
Scand J Rheumatol; 2007; 36(3):244-5; author reply 245. PubMed ID: 17657687
[No Abstract] [Full Text] [Related]
25. Leukocytoclastic vasculitis associated with tumor necrosis factor-alpha blocking agents.
Mohan N; Edwards ET; Cupps TR; Slifman N; Lee JH; Siegel JN; Braun MM
J Rheumatol; 2004 Oct; 31(10):1955-8. PubMed ID: 15468359
[TBL] [Abstract][Full Text] [Related]
26. Anaphylaxis to etanercept in two children with juvenile idiopathic arthritis.
Crayne CB; Gerhold K; Cron RQ
J Clin Rheumatol; 2013 Apr; 19(3):129-31. PubMed ID: 23519173
[TBL] [Abstract][Full Text] [Related]
27. Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis.
Culy CR; Keating GM
Drugs; 2002; 62(17):2493-537. PubMed ID: 12421111
[TBL] [Abstract][Full Text] [Related]
28. Secondary syphilis following tumor necrosis factor-α inhibitor treatment for rheumatoid arthritis.
Asahina A; Ishii N; Tohma S
J Dermatol; 2012 Feb; 39(2):199-201. PubMed ID: 21463364
[No Abstract] [Full Text] [Related]
29. Adalimumab in juvenile rheumatoid arthritis.
Taddio A; Marchetti F
N Engl J Med; 2008 Dec; 359(23):2495-6; author reply 2496-7. PubMed ID: 19065749
[No Abstract] [Full Text] [Related]
30. Cutaneous lymphocytic vasculitis during TNFalpha antagonist therapy for polyarthritis.
Wendling D; Streit G; Lehuédé G; Toussirot E; Aubin A; Petitjean A
Joint Bone Spine; 2006 Mar; 73(2):215-6. PubMed ID: 16213773
[No Abstract] [Full Text] [Related]
31. COMET's path, and the new biologicals in rheumatoid arthritis.
Kremer JM
Lancet; 2008 Aug; 372(9636):347-8. PubMed ID: 18635257
[No Abstract] [Full Text] [Related]
32. Etanercept treatment in juvenile idiopathic arthritis: the Polish registry.
Zuber Z; Rutkowska-Sak L; Postępski J; Dobrzyniecka B; Opoka-Winiarska V; Kobusińska K; Gietka P; Osińska V; Turowska-Heydel D; Szczygielska I; Kołodziejczyk B; Świątek-Baczkowska A; Gazda A; Wiland P; Tłustochowicz W; Tuszkiewicz-Misztal E
Med Sci Monit; 2011 Dec; 17(12):SR35-42. PubMed ID: 22129916
[TBL] [Abstract][Full Text] [Related]
33. Trials reveal promising options for treating juvenile rheumatoid arthritis.
Hampton T
JAMA; 2008 Jan; 299(1):27-8. PubMed ID: 18167400
[No Abstract] [Full Text] [Related]
34. Rheumatoid arthritis: still a chronic disease.
Miossec P
Lancet; 2013 Mar; 381(9870):884-6. PubMed ID: 23332235
[No Abstract] [Full Text] [Related]
35. Demyelinating disease and cutaneous lymphocitic vasculitis after etanercept therapy in a patient with rheumatoid arthritis.
Martínez-Taboada VM; Val-Bernal JF; Pesquera LC; Fernández-Llanio NE; Esteban JM; Blanco R; Alonso-Bartolome P; Gonzalez-Vela C; Rodríguez-Valverde V
Scand J Rheumatol; 2006; 35(4):322-3. PubMed ID: 16882599
[No Abstract] [Full Text] [Related]
36. [Therapy of rheumatoid arthritis with etanercept].
Lamprecht P; Nitschmann S
Internist (Berl); 2009 May; 50(5):633-4. PubMed ID: 19350212
[No Abstract] [Full Text] [Related]
37. Leukocytoclastic vasculitis due to etanercept.
Galaria NA; Werth VP; Schumacher HR
J Rheumatol; 2000 Aug; 27(8):2041-4. PubMed ID: 10955351
[TBL] [Abstract][Full Text] [Related]
38. Crohn's disease in a patient with juvenile idiopathic arthritis after starting etanercept therapy - causal link or only temporal coincidence?
Flemming GM; Tóth G; Gebauer C; Schuster V
Klin Padiatr; 2013 Nov; 225(6):350-1. PubMed ID: 24166091
[No Abstract] [Full Text] [Related]
39. Taiwan experience with etanercept in juvenile rheumatoid arthritis.
Lai JH
J Microbiol Immunol Infect; 2005 Dec; 38(6):451-4. PubMed ID: 16341348
[No Abstract] [Full Text] [Related]
40. Infliximab or etanercept in the treatment of children with refractory juvenile idiopathic arthritis: an open label study.
Lahdenne P; Vähäsalo P; Honkanen V
Ann Rheum Dis; 2003 Mar; 62(3):245-7. PubMed ID: 12594111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
